Drug interactions for the following drug(s)
Applies to: buPROPion HCl 100 MG Oral Tablet <> SPIRIVA 18 MCG Inhalant Powder Capsule
The metabolism of Tiotropium can be decreased when combined with Bupropion.
Applies to: SPIRIVA 18 MCG Inhalant Powder Capsule <> Cymbalta 20 MG Delayed Release Oral Capsule
The metabolism of Tiotropium can be decreased when combined with Duloxetine.
The metabolism of Duloxetine can be increased when combined with Fluticasone furoate.
Tiotropium may decrease the excretion rate of Vilanterol which could result in a higher serum level.
Applies to: Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT <> Cymbalta 20 MG Delayed Release Oral Capsule
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Duloxetine.
Applies to: buPROPion HCl 100 MG Oral Tablet <> Singulair 10 MG (montelukast sodium 10.4 MG) Oral Tablet
The metabolism of Bupropion can be decreased when combined with Montelukast.
Applies to: Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT <> Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluticasone.
Applies to: buPROPion HCl 100 MG Oral Tablet <> Cymbalta 20 MG Delayed Release Oral Capsule
The metabolism of Bupropion can be decreased when combined with Duloxetine.
Applies to: Medrol 4 MG Oral Tablet <> Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT
The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Fluticasone.
Applies to: Omeprazole 20 MG Delayed Release Oral Tablet <> buPROPion HCl 100 MG Oral Tablet
The metabolism of Bupropion can be decreased when combined with Omeprazole.
Applies to: Omeprazole 20 MG Delayed Release Oral Tablet <> Singulair 10 MG (montelukast sodium 10.4 MG) Oral Tablet
The metabolism of Omeprazole can be decreased when combined with Montelukast.
Applies to: Cymbalta 20 MG Delayed Release Oral Capsule <> Singulair 10 MG (montelukast sodium 10.4 MG) Oral Tablet
The metabolism of Duloxetine can be decreased when combined with Montelukast.
Applies to: Medrol 4 MG Oral Tablet <> Cymbalta 20 MG Delayed Release Oral Capsule
The metabolism of Duloxetine can be increased when combined with Methylprednisolone.
Applies to: Omeprazole 20 MG Delayed Release Oral Tablet <> SPIRIVA 18 MCG Inhalant Powder Capsule
The metabolism of Tiotropium can be decreased when combined with Omeprazole.
The metabolism of Montelukast can be decreased when combined with Fluticasone furoate.
Applies to: Omeprazole 20 MG Delayed Release Oral Tablet <> Cymbalta 20 MG Delayed Release Oral Capsule
The metabolism of Duloxetine can be increased when combined with Omeprazole.
Applies to: buPROPion HCl 100 MG Oral Tablet <> Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Bupropion.
The metabolism of Omeprazole can be decreased when combined with Fluticasone.
Applies to: Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT <> SPIRIVA 18 MCG Inhalant Powder Capsule
Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Tiotropium.
The metabolism of Montelukast can be decreased when combined with Fluticasone.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: buPROPion HCl 100 MG Oral Tablet <> SPIRIVA 18 MCG Inhalant Powder Capsule
Drug1 (rxcui = 993687, name = bupropion hydrochloride 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 580261, name = tiotropium 0.018 MG Inhalation Powder [Spiriva], tty = SBD). Drug1 is resolved to bupropion, Drug2 is resolved to tiotropium and interaction asserted in DrugBank between Bupropion and Tiotropium.
Applies to: SPIRIVA 18 MCG Inhalant Powder Capsule <> Cymbalta 20 MG Delayed Release Oral Capsule
Drug1 (rxcui = 580261, name = tiotropium 0.018 MG Inhalation Powder [Spiriva], tty = SBD). Drug2 (rxcui = 596928, name = duloxetine 20 MG Delayed Release Oral Capsule [Cymbalta], tty = SBD). Drug1 is resolved to tiotropium, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Tiotropium and Duloxetine.
Drug1 (rxcui = 596928, name = duloxetine 20 MG Delayed Release Oral Capsule [Cymbalta], tty = SBD). Drug2 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug1 is resolved to duloxetine, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Duloxetine and Fluticasone furoate. Drug1 is resolved to duloxetine, Drug2 is resolved to vilanterol and interaction asserted in DrugBank between Duloxetine and Vilanterol.
Drug1 (rxcui = 580261, name = tiotropium 0.018 MG Inhalation Powder [Spiriva], tty = SBD). Drug2 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug1 is resolved to tiotropium, Drug2 is resolved to vilanterol and interaction asserted in DrugBank between Tiotropium and Vilanterol.
Applies to: Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT <> Cymbalta 20 MG Delayed Release Oral Capsule
Drug1 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug2 (rxcui = 596928, name = duloxetine 20 MG Delayed Release Oral Capsule [Cymbalta], tty = SBD). Drug1 is resolved to fluticasone propionate, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Fluticasone propionate and Duloxetine. Drug1 is resolved to fluticasone, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Fluticasone and Duloxetine.
Applies to: buPROPion HCl 100 MG Oral Tablet <> Singulair 10 MG (montelukast sodium 10.4 MG) Oral Tablet
Drug1 (rxcui = 993687, name = bupropion hydrochloride 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 153892, name = montelukast 10 MG Oral Tablet [Singulair], tty = SBD). Drug1 is resolved to bupropion, Drug2 is resolved to montelukast and interaction asserted in DrugBank between Bupropion and Montelukast.
Applies to: Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT <> Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT
Drug1 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug2 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to vilanterol and interaction asserted in DrugBank between Fluticasone propionate and Vilanterol. Drug1 is resolved to vilanterol, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Vilanterol and Fluticasone propionate. Drug1 is resolved to fluticasone, Drug2 is resolved to vilanterol and interaction asserted in DrugBank between Fluticasone and Vilanterol. Drug1 is resolved to vilanterol, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Vilanterol and Fluticasone. Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone and Fluticasone propionate. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone propionate.
Applies to: buPROPion HCl 100 MG Oral Tablet <> Cymbalta 20 MG Delayed Release Oral Capsule
Drug1 (rxcui = 993687, name = bupropion hydrochloride 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 596928, name = duloxetine 20 MG Delayed Release Oral Capsule [Cymbalta], tty = SBD). Drug1 is resolved to bupropion, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Bupropion and Duloxetine.
Applies to: Medrol 4 MG Oral Tablet <> Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT
Drug1 (rxcui = 260330, name = methylprednisolone 4 MG Oral Tablet [Medrol], tty = SBD). Drug2 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug1 is resolved to methylprednisolone, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Methylprednisolone and Fluticasone. Drug1 is resolved to methylprednisolone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Methylprednisolone and Fluticasone furoate. Drug1 is resolved to methylprednisolone, Drug2 is resolved to vilanterol and interaction asserted in DrugBank between Methylprednisolone and Vilanterol. Drug1 is resolved to methylprednisolone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Methylprednisolone and Fluticasone propionate.
Applies to: Omeprazole 20 MG Delayed Release Oral Tablet <> buPROPion HCl 100 MG Oral Tablet
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 993687, name = bupropion hydrochloride 100 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to bupropion and interaction asserted in DrugBank between Omeprazole and Bupropion.
Applies to: Omeprazole 20 MG Delayed Release Oral Tablet <> Singulair 10 MG (montelukast sodium 10.4 MG) Oral Tablet
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 153892, name = montelukast 10 MG Oral Tablet [Singulair], tty = SBD). Drug1 is resolved to omeprazole, Drug2 is resolved to montelukast and interaction asserted in DrugBank between Omeprazole and Montelukast.
Applies to: Cymbalta 20 MG Delayed Release Oral Capsule <> Singulair 10 MG (montelukast sodium 10.4 MG) Oral Tablet
Drug1 (rxcui = 596928, name = duloxetine 20 MG Delayed Release Oral Capsule [Cymbalta], tty = SBD). Drug2 (rxcui = 153892, name = montelukast 10 MG Oral Tablet [Singulair], tty = SBD). Drug1 is resolved to duloxetine, Drug2 is resolved to montelukast and interaction asserted in DrugBank between Duloxetine and Montelukast.
Applies to: Medrol 4 MG Oral Tablet <> Cymbalta 20 MG Delayed Release Oral Capsule
Drug1 (rxcui = 260330, name = methylprednisolone 4 MG Oral Tablet [Medrol], tty = SBD). Drug2 (rxcui = 596928, name = duloxetine 20 MG Delayed Release Oral Capsule [Cymbalta], tty = SBD). Drug1 is resolved to methylprednisolone, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Methylprednisolone and Duloxetine.
Applies to: Omeprazole 20 MG Delayed Release Oral Tablet <> SPIRIVA 18 MCG Inhalant Powder Capsule
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 580261, name = tiotropium 0.018 MG Inhalation Powder [Spiriva], tty = SBD). Drug1 is resolved to omeprazole, Drug2 is resolved to tiotropium and interaction asserted in DrugBank between Omeprazole and Tiotropium.
Drug1 (rxcui = 153892, name = montelukast 10 MG Oral Tablet [Singulair], tty = SBD). Drug2 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug1 is resolved to montelukast, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Montelukast and Fluticasone furoate.
Applies to: Omeprazole 20 MG Delayed Release Oral Tablet <> Cymbalta 20 MG Delayed Release Oral Capsule
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 596928, name = duloxetine 20 MG Delayed Release Oral Capsule [Cymbalta], tty = SBD). Drug1 is resolved to omeprazole, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Omeprazole and Duloxetine.
Applies to: buPROPion HCl 100 MG Oral Tablet <> Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT
Drug1 (rxcui = 993687, name = bupropion hydrochloride 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug1 is resolved to bupropion, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Bupropion and Fluticasone propionate. Drug1 is resolved to bupropion, Drug2 is resolved to vilanterol and interaction asserted in DrugBank between Bupropion and Vilanterol.
Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug1 is resolved to omeprazole, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Omeprazole and Fluticasone. Drug1 is resolved to omeprazole, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Omeprazole and Fluticasone furoate. Drug1 is resolved to omeprazole, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Omeprazole and Fluticasone propionate.
Applies to: Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT <> SPIRIVA 18 MCG Inhalant Powder Capsule
Drug1 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug2 (rxcui = 580261, name = tiotropium 0.018 MG Inhalation Powder [Spiriva], tty = SBD). Drug1 is resolved to fluticasone propionate, Drug2 is resolved to tiotropium and interaction asserted in DrugBank between Fluticasone propionate and Tiotropium.
Drug1 (rxcui = 1648785, name = 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo], tty = SBD). Drug2 (rxcui = 153892, name = montelukast 10 MG Oral Tablet [Singulair], tty = SBD). Drug1 is resolved to fluticasone, Drug2 is resolved to montelukast and interaction asserted in DrugBank between Fluticasone and Montelukast. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to montelukast and interaction asserted in DrugBank between Fluticasone propionate and Montelukast.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.